Topics

NHS strikes deal with Vertex for transformative cystic fibrosis drugs

05:40 EDT 25 Oct 2019 | EPM Magazine

After years of negotiations, NHS England has signed an agreement with Vertex Pharmaceuticals to make the company’s suite of cystic fibrosis medicines available to patients in England.

Original Article: NHS strikes deal with Vertex for transformative cystic fibrosis drugs

NEXT ARTICLE

More From BioPortfolio on "NHS strikes deal with Vertex for transformative cystic fibrosis drugs"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...